Reply to: "Can sorafenib use influence outcome when comparing stereotactic body radiation therapy with radiofrequency ablation in patients with hepatocellular carcinoma?".
作者信息
Kim Nalee, Seong Jinsil
机构信息
Department of Radiation Oncology, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, Republic of Korea.
Department of Radiation Oncology, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, Republic of Korea.
出版信息
J Hepatol. 2020 Aug;73(2):468-469. doi: 10.1016/j.jhep.2020.04.016. Epub 2020 May 25.
PMID:32467075
Abstract
摘要
相似文献
1
Reply to: "Can sorafenib use influence outcome when comparing stereotactic body radiation therapy with radiofrequency ablation in patients with hepatocellular carcinoma?".回复：“在肝细胞癌患者中，比较立体定向体部放疗与射频消融时，索拉非尼的使用会影响结果吗？”
J Hepatol. 2020 Aug;73(2):468-469. doi: 10.1016/j.jhep.2020.04.016. Epub 2020 May 25.
2
Can sorafenib use influence outcome when comparing stereotactic body radiation therapy with radiofrequency ablation in patients with hepatocellular carcinoma?在肝细胞癌患者中，比较立体定向体部放射治疗与射频消融时，索拉非尼的使用会影响结果吗？
J Hepatol. 2020 Aug;73(2):467-468. doi: 10.1016/j.jhep.2020.03.016. Epub 2020 May 11.
3
In reply to Huo et al.: Treating small hepatocellular carcinoma: Stereotactic body radiation therapy versus radiofrequency ablation.回复霍等人：小肝细胞癌的治疗：立体定向体部放射治疗与射频消融术对比
J Gastroenterol Hepatol. 2020 Dec;35(12):2293. doi: 10.1111/jgh.15250. Epub 2020 Sep 21.
4
Radiofrequency Ablation Versus Stereotactic Body Radiotherapy for Localized Hepatocellular Carcinoma: Does Radiation Dose Make a Difference?射频消融与立体定向体部放疗治疗局限性肝细胞癌：辐射剂量有影响吗？
J Clin Oncol. 2018 Aug 20;36(24):2566-2567. doi: 10.1200/JCO.2018.78.6012. Epub 2018 Jun 26.
5
Reply to: "Stereotactic body radiation therapy vs. radiofrequency ablation for HCC: More questions than answers".回复：“立体定向体部放射治疗与射频消融治疗肝癌：问题多于答案”
J Hepatol. 2020 Oct;73(4):973-974. doi: 10.1016/j.jhep.2020.05.031. Epub 2020 Jul 6.
6
Are Head-to-Head Comparisons Between Radiofrequency Ablation and Stereotactic Body Radiotherapy Really Necessary for Localized Hepatocellular Carcinoma?对于局限性肝细胞癌，射频消融与立体定向体部放疗之间真的需要进行直接比较吗？
J Clin Oncol. 2018 Aug 20;36(24):2563-2564. doi: 10.1200/JCO.2018.78.2805. Epub 2018 Jun 26.
7
Radiofrequency Ablation Versus Stereotactic Body Radiotherapy for Hepatocellular Carcinoma: Caution When Interpreting Observational Data.射频消融术与立体定向体部放射治疗肝细胞癌：解读观察性数据时需谨慎
J Clin Oncol. 2018 Aug 20;36(24):2558. doi: 10.1200/JCO.2018.78.0122. Epub 2018 Jun 26.
8
Radiofrequency Ablation Versus Stereotactic Body Radiotherapy for Hepatocellular Carcinoma: No Way Out Without a Randomized Trial?肝细胞癌的射频消融与立体定向体部放疗：没有随机试验就无路可走？
J Clin Oncol. 2018 Aug 20;36(24):2558-2559. doi: 10.1200/JCO.2018.78.1005. Epub 2018 Jun 26.
9
Stereotactic body radiation therapy vs. radiofrequency ablation in HCC: comparing noncomparable data.立体定向体部放射治疗与射频消融治疗肝细胞癌：比较不可比的数据。
J Hepatol. 2020 Sep;73(3):727-728. doi: 10.1016/j.jhep.2020.04.017. Epub 2020 May 15.
10
What Role Does Locally Ablative Stereotactic Body Radiotherapy Play Versus Radiofrequency Ablation in Localized Hepatocellular Carcinoma?在局限性肝细胞癌中，局部消融性立体定向体部放疗与射频消融相比发挥着怎样的作用？
J Clin Oncol. 2018 Aug 20;36(24):2560-2561. doi: 10.1200/JCO.2018.78.1740. Epub 2018 Jun 26.
Zotero 插件